Additionally, patients with both CEA and type IV collagen elevated above the median had a significantly poorer survival (47 %), compared to patients with only one (70 %) or no marker elevated (92 %) 3 years after surgery, implying a prognostic significance using the combination of tumour markers in CLM patients. Here, CEACAM5 is linked to neoplasm.